Luca Mancinelli

Cesena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis.

Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis.

Journal: Frontiers in immunology

Published: July 12, 2026

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Journal: Journal of neurology

Published: March 22, 2026

Harmonized magnetic resonance imaging protocols for multiple sclerosis: HARMONY-MS, a pilot project.

Harmonized magnetic resonance imaging protocols for multiple sclerosis: HARMONY-MS, a pilot project.

Journal: Journal of neurology

Published: October 04, 2025

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Journal: CNS drugs

Published: September 28, 2025

Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study.

Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study.

Journal: Therapeutic advances in neurological disorders

Published: June 10, 2025

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Journal: Multiple sclerosis and related disorders

Published: June 09, 2024

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.

Journal: Journal of neurology

Published: January 15, 2024

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2022

Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy.

Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy.

Journal: Neuroepidemiology

Published: November 02, 2020

A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.

A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.

Journal: European journal of neurology

Published: May 30, 2020

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.

Journal: European journal of neurology

Published: May 21, 2020

Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31.

Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 18, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026